Education
About Us
Working with TipRanks
Follow Us
Curaleaf Holdings (TSE:CURA)
TSX:CURA
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.09Last Year’s EPS
-0.1Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 03, 2025
|% Change Since: -30.29%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
Curaleaf's earnings call reflected a mixed performance in 2024, with stable overall revenue and significant international growth offsetting domestic retail declines and net losses. The company is optimistic about new product launches and market expansion, but faces ongoing challenges with price compression and debt management.Company Guidance
During the Curaleaf Holdings Fourth Quarter and Fiscal Year End 2024 Earnings Call, the company reported a stable revenue of $1.34 billion for 2024, maintaining the same level as the previous year despite a 14% industry-wide price compression. The adjusted gross margin increased by 160 basis points to 48%, while adjusted EBITDA remained flat at $301 million. In the fourth quarter, Curaleaf generated $331 million in revenue, with an adjusted gross margin of 48% and adjusted EBITDA of $76 million, resulting in a 23% EBITDA margin. The company ended the year with $107 million in cash and generated $163 million in operating cash flow and $70 million in free cash flow. Curaleaf plans to focus on organic growth, margin enhancement, and cash flow generation in 2025 through its "Return to Our Roots" initiative. The international segment showed impressive growth, with a 73% revenue increase, surpassing $100 million, while wholesale revenue increased by 25% to $304 million. The company's capital expenditures for 2024 totaled $93 million, with a reduction planned for 2025. Additionally, Curaleaf aims to reduce its debt by approximately $60 million in the coming year.Stable Revenue Despite Industry Challenges
Curaleaf reported a total revenue of $1.34 billion for 2024, flat compared to last year, despite a 14% average price compression across the industry.
International Growth Success
International revenue grew by 73%, surpassing the $100 million milestone, largely driven by strong performance in Germany and the UK.
Improved Margins
Adjusted gross margin increased by 160 basis points to 48% for the year, reflecting enhanced efficiency and productivity.
Ohio and New York Market Expansion
Ohio experienced 96% growth in the second half of 2024, while New York saw a 50% increase in state growth, driven by strong triple-digit growth in wholesale.
Launch of Innovative Products
Curaleaf introduced new products like the Anthem pre-roll brand and ACE oil processing technology, which are expected to drive future growth.
---
TSE:CURA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:CURA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 03, 2025 | C$1.75 | C$1.52 | -13.14% |
| Nov 06, 2024 | C$3.04 | C$3.09 | +1.64% |
| Aug 07, 2024 | C$4.40 | C$4.63 | +5.23% |
| May 09, 2024 | C$7.35 | C$7.50 | +2.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Curaleaf Holdings (TSE:CURA) report earnings?
Curaleaf Holdings (TSE:CURA) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Curaleaf Holdings (TSE:CURA) earnings time?
Curaleaf Holdings (TSE:CURA) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CURA EPS forecast?
TSE:CURA EPS forecast for the fiscal quarter 2025 (Q1) is -0.09.
---
